Adolescent Vaccination in Pharmacies
| Status: | Completed |
|---|---|
| Healthy: | No |
| Age Range: | 11 - 18 |
| Updated: | 4/26/2018 |
| Start Date: | July 2015 |
| End Date: | April 2018 |
Building Evidence to Expand Adolescent Vaccination in Pharmacies
The study aims to expand the evidence supporting pharmacy provision of adolescent vaccines,
including human papillomavirus (HPV) vaccine. In the first part of the study, we will
characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in
a national survey. In the second part of the study, we will provide HPV vaccines and other
vaccines (Tdap, meningococcal, varicella, influenza) to 200 adolescents in a local community
pharmacy in Chapel Hill, North Carolina. This portion of the study will identify the systems
and workflow needed to provide vaccines effectively and safely, characterize parents' and
their adolescents' attitudes toward receiving vaccine services in a pharmacy, and
characterize pharmacists' attitudes toward providing adolescent vaccine services in a
pharmacy.
including human papillomavirus (HPV) vaccine. In the first part of the study, we will
characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in
a national survey. In the second part of the study, we will provide HPV vaccines and other
vaccines (Tdap, meningococcal, varicella, influenza) to 200 adolescents in a local community
pharmacy in Chapel Hill, North Carolina. This portion of the study will identify the systems
and workflow needed to provide vaccines effectively and safely, characterize parents' and
their adolescents' attitudes toward receiving vaccine services in a pharmacy, and
characterize pharmacists' attitudes toward providing adolescent vaccine services in a
pharmacy.
NATIONAL SURVEY (probability sample)
Inclusion Criteria:
- Being a member of the GfK Knowledge Panel
- Having a child age 11-18.
Exclusion Criteria:
● None
PHARMACY DEMONSTRATION PROJECT (convenience sample)
Inclusion Criteria:
- Having an adolescent child, ages 11-18 years old, who is healthy, and for whom HPV
vaccine is indicated
- Child is with the parent
Exclusion Criteria:
● Being the parent of an adolescent who is immunocompromised, or has other chronic illness,
has known anaphylactoid/hypersensitivity reactions to components of HPV vaccine used, or is
pregnant or plan to be pregnant within a month of vaccination.
We found this trial at
2
sites
Durham, North Carolina 27704
Principal Investigator: Noel T Brewer, PhD
Phone: 626-757-1504
Click here to add this to my saved trials
Durham, North Carolina 27713
Principal Investigator: Noel T Brewer, PhD
Phone: 626-757-1504
Click here to add this to my saved trials